NABEEL OMAR: Open Payments
NPI 1306627427 · SOUTHGATE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 72 payments from 22 companies in 2025. Trend: 2023 $18 · 2024 $994 · 2025 $1,512
Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $207 |
| ABBVIE INC. | 11 | $199 |
| Ardelyx, Inc. | 7 | $196 |
| Amgen Inc. | 4 | $171 |
| Indivior Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Forte Bio-Pharma LLC | 4 | $60 |
| Exact Sciences Corporation | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $57 |
Products named: IBSRELA, Wegovy, VRAYLAR, Rybelsus, SUBLOCADE, TRELEGY ELLIPTA, PROLATE, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
